Work

Establishing Clinical Relevance in Preclinical Alzheimer’s Disease

Year: 2015

Type: article

Source: The Journal of Prevention of Alzheimer s Disease

DOI: 10.14283/jpad.2015.56

Authors: R.A. Sperling, R.E. Amariglio, G.A. Marshall, D.M. Rentz

Institutions: Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Alzheimer's Association, Eli Lilly and Company, Eisai, Fidelity Biosciences, National Institute on Aging

Awards: G1129981694, G1609492295, Subjective cognitive complaints: An early indicator of AD, G3370591747, G3652633055, Mentoring Imaging Research in Early AD, Alzheimer's Disease Cooperative Study (ADCS), G5021443450, Disentangling the contribution of tau to aging and AD, Evolution of memory related fMRI activation over the course of MCI and AD, Optimizing measures of subjective and objective decline in preclinical AD, G655563530, Alzheimer's Disease Cooperative Study, PIB binding, hypometabolism, apathy and executive dysfunction in MCI and AD, G9000108150, Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study

OpenAlex ID: W2416222146

FWCI: 1.352

Cites: 16

Cited by: 9

Related to: 10